What the Final CMS Rule Means for Home Health Agencies & What That Means If You Want to Sell

On December 2, 2025, the Centers for Medicare & Medicaid Services (CMS) released the much-anticipated 2026 final rule for the Home Health Prospective Payment System (HH PPS) — and the news is sobering. After aggressive proposed cuts earlier this summer, the final rule confirms a 1.3% net reduction in Medicare payments to home health agencies (HHAs), equating to roughly $220 million industry-wide.
View the CMS Fact Sheet

For agency owners, this isn’t just a policy update — it’s a material shift that could reshape agency valuations, influence buyer demand, and reshape exit strategies. At Vallexa Advisors, we believe it’s critical to understand the full implications of this rule — and what action you should consider if you’re thinking “how much is my home health worth,” “sell my home health agency,” or “sell my home care company.”

🔎 Overview: What the Final Rule Does (and Doesn’t Do)

• Aggregate Medicare payments to HHAs in 2026 are slated for a 1.3% decrease (≈ $220M less than 2025). Alliance for Home Care Summary
• The reduction occurs despite a 2.4% market-basket increase — because permanent and temporary adjustments, updated loss-payment ratios, and recalibrated case-mix weights under the Patient-Driven Groupings Model (PDGM) offset the increase. CMS: PDGM Adjustments
• The rule finalizes additional changes including updated functional impairment scoring, revised LUPA thresholds, modifications to face-to-face requirements, and updates to the HH Quality Reporting Program (HH QRP) and Home Health Value-Based Purchasing (HHVBP) model. ThinkHomeCare Industry Details
• While the cut is much smaller than the original proposed 6.4%, many industry leaders warn that ongoing payment reductions continue to destabilize small agencies and threaten access to care. Home Health Care News Commentary

🗣️ Industry Reaction — “It Doesn’t Cure the Illness”

According to reporting from Home Health Care News, the sentiment across the home health community is one of frustration and fatigue; while the final cut was reduced, the system remains under strain.
Read the HHCN Reaction Here

Stakeholders warn that:

• Access to home-based care may shrink further, especially in rural or low-margin regions.
  Source
• Staffing pressures may intensify as reimbursement fails to keep up with labor costs.
  Source
• Without reimbursement updates that reflect the true cost of providing care, many agencies will struggle or consider exiting the market.
  Source

💡 What This Means If You’re Considering Selling or Valuing Your Agency

If you are considering selling your home health agency, this rule has real implications for valuation, exit timing, and buyer behavior.

• Downward pressure on revenue and margins: Lower Medicare reimbursement compresses EBITDA. Buyers will factor that risk into lower offers — unless strong operational controls and diversified payer mix are demonstrated.
• Operational complexity increases: PDGM, compliance scrutiny, and quality reporting enhancements place administrative burden on agencies. Strong compliance becomes a valuation advantage.
• Market consolidation accelerates: We expect increased acquisition activity as smaller agencies struggle to remain profitable.
• Valuation timing matters: If future payment cuts occur, agencies waiting too long may face reduced valuation multiples.

🛠️ What You Should Do Next — Smart Agency Moves in 2026

To protect — and potentially increase — your agency’s value, we recommend:

• Conducting a full financial and compliance audit
• Strengthening documentation, coding, and PDGM workflow controls
• Aligning staffing and scheduling to reduce inefficiencies
• Understanding your agency’s true valuation with expert M&A analysis
• Beginning exit-planning conversations early

Why Vallexa Advisors M&A is Your Strategic Edge

At Vallexa Advisors, we specialize exclusively in home health and home care M&A. We understand how regulatory pressures shape valuation and acquisition strategy — and we help agencies protect the value they’ve built.

We can help you:

• Complete a valuation under post-rule economics
• Optimize compliance and financial presentation before going to market
• Build a buyer-ready “book of business”
• Navigate negotiations, LOIs, diligence, and closing

If you’ve been asking “how much is my home health worth?”, “sell my home care company,” or “how do I sell my home health agency?”, now is the time to act. Contact Vallexa Advisors — we will help you gain clarity, protect your agency, and move forward with confidence.

Frequently Asked Questions

Details & Expanded Insights

How the CMS Final Rule Impacts Your Revenue

The 1.3% net payment reduction directly affects Medicare reimbursement under PDGM. Even a small percentage cut translates into significant annualized revenue compression, especially for agencies with high Medicare census. Reduced reimbursement impacts operating margins, staffing capacity, and long-term growth potential.

Why These Changes Influence Valuation

Buyers evaluate cash flow durability under regulatory pressure. When CMS reductions coincide with rising labor costs and compliance requirements, valuations tend to tighten. Agencies with strong financial controls, diversified payer mix, and consistent staffing stability retain higher valuation multiples.

What Buyers Look for in This Market

In 2026 and beyond, buyers prioritize agencies that demonstrate operational resilience, PDGM literacy, clean documentation, low audit risk, and strong referral stability. Agencies lacking these characteristics often experience longer diligence cycles or discounted offers.

When to Consider Selling Your Home Health Agency

With reimbursement declining and consolidation accelerating, many owners choose to explore exit strategies while valuations remain defensible. If you’re unsure of your agency’s current value, a readiness assessment or confidential valuation can clarify your best timing.